EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 117 filers reported holding EPIZYME INC in Q3 2021. The put-call ratio across all filers is 1.61 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $150,000 | -46.8% | 130,067 | +15.4% | 0.00% | – |
| Q4 2021 | $282,000 | -51.6% | 112,716 | -1.0% | 0.00% | -100.0% |
| Q3 2021 | $583,000 | -47.0% | 113,839 | -14.1% | 0.00% | 0.0% |
| Q2 2021 | $1,101,000 | -16.3% | 132,530 | -12.3% | 0.00% | -50.0% |
| Q1 2021 | $1,316,000 | -20.5% | 151,106 | -0.9% | 0.00% | 0.0% |
| Q4 2020 | $1,656,000 | -8.1% | 152,481 | +0.9% | 0.00% | -33.3% |
| Q3 2020 | $1,802,000 | -33.8% | 151,055 | -10.9% | 0.00% | -40.0% |
| Q2 2020 | $2,724,000 | +29.1% | 169,583 | +24.7% | 0.01% | +25.0% |
| Q1 2020 | $2,110,000 | -32.0% | 136,025 | +7.9% | 0.00% | -20.0% |
| Q4 2019 | $3,101,000 | +145.5% | 126,048 | +3.0% | 0.01% | +150.0% |
| Q3 2019 | $1,263,000 | -18.4% | 122,402 | -0.7% | 0.00% | -33.3% |
| Q2 2019 | $1,547,000 | +20.7% | 123,276 | +19.1% | 0.00% | +50.0% |
| Q1 2019 | $1,282,000 | +132.7% | 103,466 | +15.7% | 0.00% | +100.0% |
| Q4 2018 | $551,000 | +2.8% | 89,394 | +76.9% | 0.00% | 0.0% |
| Q3 2018 | $536,000 | -24.8% | 50,542 | -4.0% | 0.00% | 0.0% |
| Q2 2018 | $713,000 | -16.7% | 52,650 | +9.2% | 0.00% | -50.0% |
| Q1 2018 | $856,000 | +54.8% | 48,210 | +9.4% | 0.00% | +100.0% |
| Q4 2017 | $553,000 | -42.6% | 44,080 | -12.9% | 0.00% | -50.0% |
| Q3 2017 | $964,000 | +27.3% | 50,620 | +1.0% | 0.00% | 0.0% |
| Q2 2017 | $757,000 | -9.7% | 50,140 | +2.6% | 0.00% | 0.0% |
| Q1 2017 | $838,000 | +46.0% | 48,883 | +3.1% | 0.00% | +100.0% |
| Q4 2016 | $574,000 | +37.6% | 47,435 | +12.0% | 0.00% | 0.0% |
| Q3 2016 | $417,000 | -1.7% | 42,339 | +2.2% | 0.00% | 0.0% |
| Q2 2016 | $424,000 | -1.9% | 41,419 | +16.1% | 0.00% | 0.0% |
| Q1 2016 | $432,000 | -2.5% | 35,679 | +29.1% | 0.00% | 0.0% |
| Q4 2015 | $443,000 | +33.4% | 27,634 | +7.2% | 0.00% | 0.0% |
| Q3 2015 | $332,000 | -44.1% | 25,779 | +4.1% | 0.00% | -50.0% |
| Q2 2015 | $594,000 | +152.8% | 24,760 | +97.8% | 0.00% | +100.0% |
| Q1 2015 | $235,000 | +16.3% | 12,515 | +16.8% | 0.00% | 0.0% |
| Q4 2014 | $202,000 | -31.8% | 10,715 | -1.8% | 0.00% | 0.0% |
| Q3 2014 | $296,000 | -9.5% | 10,915 | +3.8% | 0.00% | 0.0% |
| Q2 2014 | $327,000 | +55.7% | 10,515 | +101.2% | 0.00% | 0.0% |
| Q3 2013 | $210,000 | – | 5,225 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 9,166,667 | $109,358,000 | 16.39% |
| Burrage Capital Management LLC | 1,002,528 | $11,960,000 | 9.44% |
| Foresite Capital Management III, LLC | 998,278 | $11,909,000 | 8.87% |
| MPM BioImpact LLC | 2,854,737 | $34,057,000 | 8.20% |
| Palo Alto Investors LP | 6,403,600 | $76,395,000 | 4.19% |
| Foresite Capital Management II, LLC | 862,402 | $10,288,000 | 2.24% |
| Redmile Group, LLC | 8,311,633 | $99,158,000 | 1.82% |
| Pier Capital, LLC | 574,299 | $6,851,000 | 1.00% |
| Foresite Capital Management I, LLC | 243,759 | $2,908,000 | 0.82% |
| Rock Springs Capital Management LP | 2,551,659 | $30,441,000 | 0.77% |